LRRK2-NFATc2 Pathway Associated with Neuroinflammation May Be a Potential Therapeutic Target for Parkinson’s Disease
Authors:
Open Access
- 1 June 2021
- journal article
- editorial
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 14, 2583-2586
Abstract
Neuroinflammation plays an important role in the pathogenesis of Parkinson’s disease (PD). However, the molecular mechanisms involved in extracellular α‑synuclein-induced proinflammatory microglial responses through Toll-like receptor 2 (TLR2) are unclear. Leucine-rich repeat kinase 2 (LRRK2) is a serine/threonine kinase, and its mutations are closely related to autosomal dominant PD. Recently, Masliah et al characterized a novel-specific neuroinflammation cascade dependent on LRRK2-NFATc2 in microglia activated by neuron-released α-synuclein. LRRK2 selectively phosphorylated and induced nuclear translocation of NFATc2 to activate a neuroinflammation cascade. In this cascade, LRRK2 kinase was activated by neuron-released α-synuclein in microglia via TLR2. Further, NFATc2, as a kinase substrate for LRRK2, was directly phosphorylated, which accelerated nuclear translocation of NFATc2, where cytokine/chemokine gene expression including TNF-α and IL-6 is regulated by NFATc2 transcriptional activity, resulting in a neurotoxic inflammatory environment. Moreover, an abnormal increase of NFATc2 in nuclear was observed in the brains of patients and a mouse model of PD. Additionally, the administration of an LRRK2 inhibitor could ameliorate neuroinflammation, prevent neuronal loss, and improve motor function. Therefore, modulation of LRKK2-NFATc2 signaling cascade might be a potential therapeutic target for the treatment of PD.Keywords
This publication has 24 references indexed in Scilit:
- Toll-Like Receptor Expression in the Blood and Brain of Patients and a Mouse Model of Parkinson's DiseaseInternational Journal of Neuropsychopharmacology, 2014
- Extracellular α-synuclein—a novel and crucial factor in Lewy body diseasesNature Reviews Neurology, 2014
- LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?Journal of Neuroinflammation, 2014
- Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microgliaNature Communications, 2013
- NFAT control of innate immunityBlood, 2012
- The IkappaB Kinase Family Phosphorylates the Parkinson’s Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor SignalingPLOS ONE, 2012
- LRRK2 Inhibition Attenuates Microglial Inflammatory ResponsesThe Journal of Neuroscience, 2012
- NFAT, immunity and cancer: a transcription factor comes of ageNature Reviews Immunology, 2010
- Recognition and Signaling by Toll-Like ReceptorsAnnual Review of Cell and Developmental Biology, 2006
- The Interleukin-1 Receptor/Toll-Like Receptor Superfamily: Signal Transduction During Inflammation and Host DefenseScience's STKE, 2003